| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Platin | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.4 |
| mRNA | MK-2206 | GDSC1000 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.048 | 0.4 |
| mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.4 |
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.5 |
| mRNA | 681640 | GDSC1000 | pan-cancer | AAC | -0.028 | 0.5 |
| mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.5 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |